Clinical trial Recruiting at 1 site Interventional Ages 18 and up

VR-based sensory stimulation to prevent delirium in ICU patients

Official title: Virtual Reality-based Sensory Stimulation for Delirium Prevention in Intensive Care Units: A Randomized Controlled Trial

Run by Chinese University of Hong Kong · NCT07806422 · Data updated 2026-11-12

This trial tests whether immersive virtual reality sensory stimulation can delay or reduce delirium in adult ICU patients compared with a non-immersive, tablet-based sensory experience.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Locations1 site (Shenzhen, Guangdong)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedDecember 31, 2029
Study endsDecember 31, 2029
Registry record updatedSeptember 8, 2026
Trial IDNCT07806422 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) admitted to the ICU, expected to require mechanical ventilation and stay at least 48 hours, and who are awake or lightly sedated and able to consent.

Probably not a fit

Patients with pre-existing cognitive impairment, delirium at enrollment, severe sensory impairments, or conditions making VR headset use impractical may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot randomized trial compares immersive VR-based sensory stimulation to a tablet-based active control delivering the same nature-based content in adult ICU patients. Participants are randomized 1:1 and receive a single 20-minute session, with outcomes including time to first delirium, delirium incidence, duration and severity, ICU length of stay, ventilation duration, cognitive function at 3 months, and quality of life. The goal is to determine if immersion adds value beyond the sensory content alone while accounting for ICU environmental factors that contribute to delirium. The study is conducted as a collaboration between the Chinese University of Hong Kong and three Shenzhen hospitals in China.

Why it matters

Potential benefit: If successful, immersive VR sensory stimulation could reduce delirium burden and improve short- and long-term outcomes for ICU patients.

How similar studies have gone: Previous sensory stimulation approaches have shown potential to delay delirium onset, but this VR-immersion approach is novel in ICU delirium prevention and its additive benefit is being tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older
* Admitted to the ICU
* Undergoing or expected to require mechanical ventilation
* Expected ICU stay of at least 48 hours
* Awake or lightly sedated, defined as a Richmond Agitation-Sedation Scale - (RASS) score between -1 and +1
* Able to understand and follow instructions
* Provided informed consent \[or surrogate consent, if applicable\]

Exclusion Criteria:

* Pre-existing cognitive impairment or dementia
* Acute psychiatric illness at admission
* Delirium at enrollment as assessed by CAM-ICU
* Terminal-stage cancer
* APACHE II score \> 20
* Severe uncorrectable hearing or visual impairment
* Traumatic brain injury or intracranial drainage tubes that make use of the VR headset impractical

Where it's running

  • Southern Medical University Shenzhen Hospital, Peking University Shenzhen Hospital, Shenzhen People's Hospital
    Shenzhen, Guangdong, China
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Can family members spot delirium signs in ICU patients?

    Family members who know the patient well try a quick delirium check after visiting in the ICU, to see if their observations add information beyond routine nurse screenings.

    Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07694687

  • Digital and Plasma Biomarkers for Delirium in the ICU

    This study tests whether digital biomarkers and blood biomarkers can help detect and predict delirium in older adults in the ICU.

    Recruiting Scripps Health · La Jolla, California and 1 other locations · NCT07694206

  • Therapeutic cuddling for critically ill children

    This project will try therapeutic cuddling to reduce pain, agitation, and delirium in children admitted to the pediatric intensive care unit.

    Recruiting University of Calgary · Calgary, Alberta · NCT07562048

  • Ceribell EEG monitoring for adults in the ICU at high risk of delirium

    This project will test whether a portable Ceribell EEG can detect abnormal brain activity in adult medical, surgical, and cardiovascular ICU patients at high risk for delirium.

    Recruiting Ceribell Inc. · Nashville, Tennessee · NCT07485244

  • Ceribell Delirium Monitor Pilot in ICU Patients

    This pilot test uses the Ceribell Delirium Monitor in ICU patients to see if adding EEG-based delirium monitoring is feasible and how it might affect outcomes.

    Recruiting Ceribell Inc. · Irvine, California and 1 other locations · NCT07449416

  • Impact of Family Presence on ICU Patient Outcomes

    This study looks at whether having family members present can help ICU patients need less medication, experience less confusion, spend fewer days on ventilators, and shorten their time in the ICU.

    Recruiting Istanbul University - Cerrahpasa · Istanbul · NCT06770751

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.